DNDi Recognizes 10th Anniversary

The Financial Times profiles the Drugs for Neglected Diseases Initiative (DNDi), which is recognizing its 10th anniversary this month. “DNDi has delivered six treatments for neglected diseases and has 12 ‘new chemical entities’ under development,” the newspaper writes, adding, “At €183 million [$252 million] spent to date, that translates into a modest price tag for each successfully launched medicine compared to the costs for drugs launched by drug companies” (Jack, 12/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.